Bibliometric analysis of ESKAPE drug‑resistant bacteria / 上海预防医学

ObjectiveTo conduct a bibliometric visual analysis of studies on Enterococcus faecium， Staphylococcus aureus， Klebsiella pneumoniae， Acinetobacter baumannii， Pseudomonas aeruginosa and Enterobacter species （ESKAPE） in the past 10 years at home and abroad， and to analyze current research status and future research directions in this field based on the concept of “One health”. MethodsRelated literature on ESKAPE drug resistant bacteria from 2013 to 2022 was searched on CNKI and WoS， respectively. Furthermore， a metrological visualization analysis of authors， source of agencies， countries， and keywords was conducted by the CiteSpace 6.1.R6 software. ResultsA total of 2 991 pieces of Chinese-language and 24 497 pieces of English-language literature were included in this study. Although the number and growth rate of English-language publications were higher than those of Chinese-language publications， the number of English-language papers authored by Chinese scholars showed a significant upward trend. The level of collaboration between authors and institutions in Chinese-language publications was weaker than that in English-language publications. Overall， the country with the highest number of publications was the United States （6 623）， followed by China （3 776）. However， China’s annual publication volume （851） exceeded that of the United States （600） in 2022. China had collaborations with 25 countries， indicating good global cooperation， but its level of international cooperation was still slightly weaker than that of the United States. High-frequency keywords in Chinese-language literature mainly included drug resistance， nosocomial infection， and antibiotics， while high-frequency keywords in English-language literature included Staphylococcus aureus， Klebsiella pneumoniae， and methicillin-resistant. ConclusionCarbapenem-resistant Klebsiella pneumoniae， carbapenem-resistant Enterobacteriaceae， and "One health" are research hotspots. In the future， cross-sectoral and multi-regional collaboration should be deepened to strengthen the control of infections of important drug-resistant bacteria， and infection treatment strategies should be optimized as well.

Occurrence of the bacteria in a hospital environment and their sensitivity profile to the main antimicrobials in a reference general hospital in Curitiba, Brazil / Ocorrência de bactérias em ambiente hospitalar, e seu perfil de sensibilidade aos principais antimicrobianos em um hospital de referência em Curitiba, Brasil / Ocurrencia de bacterias en ambiente hospitalario y su perfil de sensibilidad a los principales antimicrobianos en un hospital de referencia en Curitiba, Brasil

Introduction: Antimicrobial resistance rates are increasing in both hospital and community settings, creating a favorable environment for the development of superbacteria. Therefore, local studies are necessary for the proper management of current antimicrobial arsenals and for addressing the current bacteriological scenario. Aim: The aim of this study is to profile bacterial epidemiology in a hospital in Curitiba, Brazil and associate it with the effectiveness of antimicrobial therapy. Methodology: Data from 2019 to 2021 were collected by the Center for Epidemiology and Hospital Infection Control (CEHIC), and this was a quantitative single-center study. Results: The most commonly detected microorganisms were Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis, Pseudomonas aeruginosa, Enterococcus faecalis, Acinetobacter baumannii, Staphylococcus haemolyticus, Staphylococcus hominis, and Enterobacter cloacae. A. baumannii and K. pneumoniae had the lowest mean sensitivity coefficients, while S. aureus was the most sensitive. Erythromycin was the least effective antimicrobial agent, while daptomycin was the most effective. Conclusion: These results are consistent with the literature and can be used to optimize empiric therapies, as there are already important therapeutic failures associated with antimicrobial resistance.

Introdução: As taxas de resistência antimicrobiana estão em ascensão tanto em ambientes hospitalares como comunitários, criando um cenário propício para o desenvolvimento de superbactérias e, assim, torna-se necessário estudos locais para uma gestão adequada dos arsenais antimicrobianos atuais e frente ao cenário bacteriológico atual. Objetivo: O escopo desse estudo visa traçar o perfil epidemiológico bacteriano num hospital em Curitiba, Brasil e associá-lo à eficácia da terapia antimicrobiana. Metodologia: Os dados de 2019 a 2021 foram recolhidos pelo Centro de Epidemiologia e Controle de Infecções Hospitalares (CECIH), sendo este um estudo unicêntrico quantitativo. Resultados: Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis, Pseudomonas aeruginosa, Enterococcus faecalis, Acinetobacter baumannii, Staphylococcus haemolyticus, Staphylococcus hominis, e Enterobacter cloacae foram os microrganismos mais comuns detectados. A. baumannii e K. pneumoniae tinham as médias de coeficiente de sensibilidade mais baixas, enquanto S. aureus era o mais sensível. A eritromicina era o agente antimicrobiano menos eficaz, enquanto a daptomicina era o mais eficaz. Conclusão: Estes resultados estão de acordo com a literatura e podem ser utilizados para otimizar as terapias empíricas, visto que já há falhas terapêuticas importantes associadas a resistência antimicrobiana.

Introducción: Las tasas de resistencia antimicrobiana están en aumento tanto en el ámbito hospitalario como en el comunitario, creando un escenario propicio para el desarrollo de superbacterias, por lo que son necesarios estudios locales para una gestión adecuada de los actuales arsenales antimicrobianos y hacer frente al escenario bacteriológico actual. Objetivo: El alcance de este estudio pretende trazar el perfil epidemiológico bacteriano en un hospital de Curitiba, Brasil y asociarlo a la eficacia de la terapia antimicrobiana. Metodología: Los datos de 2019 a 2021 fueron recogidos por el Centro de Epidemiología y Control de Infecciones Hospitalarias (CECIH), siendo un estudio cuantitativo unicéntrico. Resultados: Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis, Pseudomonas aeruginosa, Enterococcus faecalis, Acinetobacter baumannii, Staphylococcus haemolyticus, Staphylococcus hominis y Enterobacter cloacae fueron los microorganismos más frecuentes detectados. A. baumannii y K. pneumoniae presentaron los coeficientes medios de sensibilidad más bajos, mientras que S. aureus fue el más sensible. La eritromicina fue el agente antimicrobiano menos eficaz, mientras que la daptomicina fue el más eficaz. Conclusión: Estos resultados concuerdan con la literatura y pueden ser utilizados para optimizar las terapias empíricas, pues ya existen importantes fracasos terapéuticos asociados a la resistencia antimicrobiana.

Perfil epidemiológico, clínico e microbiológico de infecções por bactérias do grupo eskape em pacientes internados em uma unidade de terapia intensiva de um hospital de ensino de Minas Gerais / Epidemiological, clinical and microbiological profile of eskape group bacteria infections in patients admitted to an intensive care unit of a teaching hospital in Minas Gerais / Perfil epidemiológico, clínico y microbiológico de las infecciones por bacterias del grupo eskape en pacientes ingresados en una unidad de cuidados intensivos de un hospital escuela de Minas Gerais

Objetivo: descrever o perfil epidemiológico de infecções por bactérias do grupo ESKAPE em pacientes internados em uma unidade de terapia intensiva de um hospital de ensino da cidade de Juiz de Fora - MG. Métodos: Trata-se de um estudo epidemiológico observacional, descritivo de caráter retrospectivo, com participantes que adquiriram IRAS entre 2017 e 2018, dos quais foram isoladas e identificadas linhagens bacterianas pertencentes ao grupo ESKAPE no serviço de rotina bacteriológica do laboratório de microbiologia clínica. Resultados: Considerando o fenótipo de multirresistência entre as bactérias do grupo ESKAPE avaliadas, foi observada a ocorrência de 122 (88,4%) para Acinetobacter baumanii resistente aos carbapenêmicos, 87 (60,8%) para Klebsiella pneumoniae resistente aos carbapenêmicos, 57 (53,3%) para Pseudomonas aeruginosa resistente aos carbapenêmicos, 36 (55,4%) para MRSA e 19 (48,7%) para Enterobacter sp. resistente aos carbapenêmicos. Conclusões: A análise do perfil epidemiológico, clínico e microbiológico de infecções por bactérias do grupo ESKAPE em pacientes internados em uma UTI é de majorada importância para protocolos de terapia com o correto manejo de antibioticoterapia e redução da prevalência de resistência antimicrobiana.

Objective: To describe the epidemiological profile of ESKAPE group bacteria infections in patients admitted to an intensive care unit of a teaching hospital in Juiz de Fora, Minas Gerais. Methods: This is an observational, descriptive epidemiological study of retrospective nature, with participants who acquired IRAS between 2017 and 2018, from which bacterial strains belonging to the ESKAPE group were isolated and identified in the bacteriological routine service of the clinical microbiology laboratory. Results: Considering the multidrug resistance phenotype among the ESKAPE group bacteria evaluated, the occurrence of 122 (88.4%) for carbapenem- resistant Acinetobacter baumanii, 87 (60.8%) for carbapenem-resistant Klebsiella pneumoniae, 57 (53.3%) for carbapenem-resistant Pseudomonas aeruginosa, 36 (55.4%) for MRSA, and 19 (48.7%) for carbapenem-resistant Enterobacter sp. was observed. Conclusions: The analysis of the epidemiological, clinical and microbiological profile of infections caused by bacteria of the ESKAPE group in patients in an ICU is of major importance for therapy protocols with the correct management of antibiotic therapy and reduction of the prevalence of antimicrobial resistance.

Objetivo: Describir el perfil epidemiológico de las infecciones por bacterias del grupo ESKAPE en pacientes internados en la unidad de terapia intensiva de un hospital escuela de Juiz de Fora, Minas Gerais. Método: Se trata de un estudio epidemiológico observacional, descriptivo, de carácter retrospectivo, con participantes que adquirieron IRAS entre 2017 y 2018, de los cuales se aislaron e identificaron cepas bacterianas pertenecientes al grupo ESKAPE en el servicio de rutina bacteriológica del laboratorio de microbiología clínica. Resultados: Considerando el fenotipo de resistencia a múltiples fármacos entre las bacterias del grupo ESKAPE evaluadas, se observó la ocurrencia de 122 (88,4%) para Acinetobacter baumanii resistente a carbapenemes, 87 (60,8%) para Klebsiella pneumoniae resistente a carbapenemes, 57 (53,3%) para Pseudomonas aeruginosa resistente a carbapenemes, 36 (55,4%) para MRSA y 19 (48,7%) para Enterobacter sp. resistente a carbapenemes. Conclusiones: El análisis del perfil epidemiológico, clínico y microbiológico de las infecciones causadas por bacterias del grupo ESKAPE en pacientes ingresados en una UCI es de gran importancia para los protocolos terapéuticos con el correcto manejo de la antibioticoterapia y la reducción de la prevalencia de resistencias antimicrobianas.

Perfil de sensibilidad y resistencia antimicrobiana de bacterias ESKAPE en las unidades de internación del Hospital del Norte 2019, La Paz-Bolivia / Antimicrobial sensitivity and resistance profile of ESKAPE bacteria in all inpatient units of the Hospital del Norte 2019, La Paz-Bolivia

INTRODUCCIÓN: la resistencia a los antimicrobianos plantea una amenaza para la salud pública a nivel mundial. Las infecciones por bacterias ESKAPE representan mayores problemas de resistencia, debido a que pueden presentar más de un mecanismo de resistencia y además tienen la facultad de transmitirlo. En Bolivia no existen artículos publicados que muestren la multirresistencia de bacterias ESKAPE en hospitales de tercer nivel. OBJETIVO: describir el perfil de sensibilidad y resistencia antimicrobiana de las bacterias ESKAPE aisladas en todas las unidades de internación del Hospital Del Norte durante la gestión 2019. MATERIAL Y MÉTODOS: estudio observacional, descriptivo, incluyó 836 aislamientos obtenidos de enero a diciembre del 2019 provenientes de pacientes internados en todas las unidades del Hospital del Norte. Se empleó el sistema WHONET y las variables estudiadas fueron: edad, género, tipo de muestra, sala de internación, perfil de sensibilidad y resistencia de cada uno de los microorganismos en estudio. RESULTADOS: Se elaboró y describió el perfil de sensibilidad y resistencia antimicrobiana de las bacterias ESKAPE, encontrándose que los Enterobacterales tienen mayor frecuencia, siendo Escherichia coli el patógeno más prevalente; se determinó que existe mayor frecuencia en pacientes adultos, con mayor prevalencia en el género femenino. La frecuencia por tipo de muestra se observa que los tres primeros lugares lo ocupan las muestras de orina, vías respiratorias bajas y abscesos. Los servicios de Terapia intensiva, Medicina Interna y Cirugía son las áreas más críticas. Se obtuvieron los porcentajes de resistencia que presentan cada uno de los microorganismos estudiados según sala de internación. Los principales mecanismos de resistencia fenotípica encontrados en este estudio, son BLEE y MRSA. CONCLUSIONES: los resultados obtenidos demuestran que el mapa epidemiológico de resistencia antimicrobiana del Hospital del Norte, presenta porcentajes más altos en relación a los mapas epidemiológicos similares de otros hospitales en Latinoamérica.

INTRODUCTION: antimicrobial resistance raises a serious threat to health worldwide. Infections by ESKAPE bacteria represent major resistance problems, since they can present more than one resistance mechanism and also have the ability to transmit other bacteria. In Bolivia, unfortunately, there are no Bolivian authors who have published articles explaining the multi-resistance of ESKAPE Bacteria in third level hospitals. OBJECTIVE: To describe the antimicrobial sensitivity and resistance profile of ESKAPE bacteria isolated in all inpatient units of Hospital Del Norte in 2019. MATERIAL AND METHODS: observational, descriptive study, included 836 isolates obtained from January to December 2019 from patients hospitalized in all units of Hospital del Norte. WHONET software was used and the variables studied were: age, gender, type of sample, hospitalization room and resistance profile of each of the microorganisms under study. RESULTS: the antimicrobial sensitivity and resistance profile of each ESKAPE bacteria was elaborated and described, and it was found that Enterobacteriaceae have a higher frequency, with Escherichia coli is being the most prevalent pathogen; it was determined that there is a higher frequency in adult patients, with a higher prevalence in the female gender. The frequency by type of sample shows that the first three places are occupied by urine, lower respiratory tract and abscess samples. Intensive care, internal medicine, and surgery services are the most critical areas. The percentages of resistance were obtained for each of the microorganisms studied according to the hospitalization room. ESBL and MRSA are the main phenotypic resistance mechanism found in the hospital. CONCLUSIONS: the results obtained show that the epidemiological map of antimicrobial resistance at Hospital del Norte presents higher percentages in relation to similar epidemiological maps of other hospitals in Latin America.

Resistencia antimicrobiana. Importancia y esfuerzos por contenerla / Antimicrobial resistance. Its importance and efforts to control it

Resumen La Organización Mundial de la Salud estima que en 2050 la resistencia bacteriana ocasionará 10 millones de muertes. Como parte del Plan de Acción Mundial sobre la Resistencia a los Antimicrobianos propuso redes de laboratorios especializados, para conservar cepas y optimizar el uso de los antimicrobianos. En un estudio de 2019 se identificó que las principales bacterias del grupo ESKAPE (con alta resistencia a los antibióticos más usados) que causan infecciones en hospitales de México son Klebsiella spp. resistentes a múltiples fármacos (MDR) y productoras de betalactamasa de espectro extendido (BLEE), Enterobacter spp. BLEE, Acinetobacter baumannii, Pseudomonas aeruginosa MDR, Staphylococcus aureus meticilinorresistente y Enterococcus faecium resistente a vancomicina. Con la información de resistencia a los fármacos se recomiendan esquemas para tratar la infección causada por Helicobacter pylori, relacionado con el desarrollo de cáncer y cuya prevalencia en la población adulta de Latinoamérica se estima es de entre 60 y 70 %.

Abstract The World Health Organization estimates that bacterial resistance will cause 10 million deaths by 2050. As part of the Global Action Plan on Antimicrobial Resistance, it proposed networks of specialized laboratories in order to preserve strains and optimize the use of antimicrobials. In a 2019 study, the main bacteria of the ESKAPE group (which are highly-resistant to the most widely used antibiotics) that cause infections in Mexican hospitals were identified to be multidrug-resistant (MDR) and extended spectrum beta-lactamase (ESBL)-producing Klebsiella spp., ESBL-producing Enterobacter spp., Acinetobacter baumannii, MDR Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. With information on drug resistance, regimens are recommended to treat infection caused by Helicobacter pylori, a pathogen related to the development of cancer and whose prevalence in the adult population of Latin America is estimated to range between 60 and 70%.